Home » Newsletters » BioWorld Science

BioWorld Science

June 21, 2012

View Archived Issues

Novel therapeutic target for multiple sclerosis identified

Novel immunocytokine for rheumatoid arthritis shows promise in early-stage clinical trial

Universities team up to unveil new biomarker predicting TTR in colon cancer

Researchers at Leo Pharma synthesize novel CaSR agonists

Merck KGaA prepares novel protein kinase inhibitors

Spanish scientists develop new agents for neurodegenerative diseases

Alnylam product receives orphan drug status

Roche and Seaside Therapeutics to collaborate on treatments for neurodevelopmental disorders

New potassium channel blockers designed at Pierre Fabre

Japanese group patents novel DCP-LA enantiomers

Pharmacokinetics of pure icaritin investigated in rats

Janssen Pharmaceutica presents new matrix metalloproteinase inhibitors

Sirona Biochem reports findings on SGLT inhibitor in primates

FDA grants orphan drug status to new therapy for AML

RGN-259 improves severe dry eye in phase II trial

Biovest to seek approval for personalized NHL vaccine

NovaRx completes enrollment in pivotal Lucanix trial

Dosing begins in phase III MuDelta studies

Data monitoring committee recommends continued enrollment in Reolysin trial

FDA advisory committee votes on carfilzomib NDA

Biopump gets orphan drug status for hepatitis D

Pozen receives FDA response regarding PA-32540 bioequivalence study

Tetra Discovery Partners receives award from NIH

Medigene to advance optimized formulation of RhuDex

Otsuka and UCB Japan seek new approvals for antiepileptic drug

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...